BioStem Technologies (OTC: BSEM), a medical device company focused on advanced wound care solutions derived from perinatal tissue, will present at the 46th Annual TD Cowen Healthcare Conference scheduled for March 2, 2026, in Boston. The presentation will provide an opportunity for investors and healthcare industry professionals to learn about the company's product portfolio and strategic initiatives.
Investors and stakeholders interested in attending the presentation remotely will have access to live and archived webcasts through BioStem's investor relations website. This appearance aligns with the company's ongoing efforts to engage with the investment community and present its position within the competitive wound care and regenerative medicine markets.
The TD Cowen Healthcare Conference is a prominent industry gathering that attracts institutional investors, healthcare professionals, and company executives seeking to discuss emerging trends and developments in the healthcare sector.